Tramadol pharmacokinetics and its possible interactions with cyclooxygenase 2-selective nonsteroidal anti-inflammatory drugs.
Punwani
Naresh G
NG
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000493:pharmacokinetics / Q000627:therapeutic use; D000068579:Celecoxib; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D004347:Drug Interactions; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D010003:Osteoarthritis / Q000175:diagnosis / Q000188:drug therapy*; D011720:Pyrazoles; D018570:Risk Assessment; D012720:Severity of Illness Index; D013449:Sulfonamides / Q000493:pharmacokinetics* / Q000627:therapeutic use; D014147:Tramadol / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; D014147:Tramadol; D000068579:Celecoxib